Evidence of a systemic disorder should also be sought, as it may indicate an underlying etiology
This is the big question for many people: If I take a GLP-1 drug, am I increasing my risk of breast canceror other cancers? So far, based on large studies, meta-analyses, and case-controlled studies, the answer appears to be: No, GLP-1 agonists do not increase overall cancer risk or breast cancer risk
Does Mounjaro interact with nicotine patches
This reduction in hyperfiltration is a key factor in stabilising the Glomerular Filtration Rate (eGFR) and lowering proteinuria levels
This matters in older adults because agerelated muscle loss (sarcopenia) is already common and its tightly linked to frailty, falls, and loss of independence